-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O1.6 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Regimens and Early Complications – Results of Prospective and Retrospective Studies

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 2:45 PM-4:15 PM
W230, Level 2 (Orange County Convention Center)
Moderators:
Andrew R. Rezvani, MD, Stanford University and Sergio A. Giralt, MD, Memorial Sloan Kettering Cancer Center

Disclosures:
Rezvani: Pharmacyclics: Research Funding .
2:45 PM

Dina Okasha1*, Amy A Kirkwood2*, Mhairi Copland, BSc (Hons) MB ChB PhD FRCP FRCPath3, Emma Lawrie4*, Andrew McMillan, PhD5, Tobias F. Menne, MD, PhD, FRCPath6*, Nick Morley7*, Clare Rowntree8*, Deborah Susan Richardson, MD, FRCPath, FRCP, MA, MBBChir9, Paul Smith4*, Adele K. Fielding, MB BS, PhD10 and David Marks, MD, PhD11

1University College London, London, United Kingdom
2CRUK and UCL Cancer Trials Centre, UCL, London, United Kingdom
3Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, United Kingdom
4UCL, London, United Kingdom
5Centre for Clinical Haematology, Nottingham City Hospitals NHS Trust, Nottingham, United Kingdom
6Level 4, Newcastle Upon Tyne, United Kingdom
7Royal Hallamshire Hospital Sheffield, Sheffield, United Kingdom
8Heath Hospital, Cardiff, United Kingdom
9University Hospitals Southampton, Southampton, United Kingdom
10Department of Hematology, UCL Cancer Institute, London, United Kingdom
11University Hospitals Bristol NHS Trust, Bristol, United Kingdom

3:00 PM

Yasuyuki Arai, MD1,2*, Kazunari Aoki, MD1*, June Takeda, MD1*, Tadakazu Kondo, MD1, Tetsuya Eto, MD, Ph.D3*, Shuichi Ota, MD4, Hisako Hashimoto, MD5*, Takahiro Fukuda, MD6*, Yukiyasu Ozawa, MD7*, Yoshinobu Kanda, MD, PhD8, Chiaki Kato, MD9*, Mineo Kurokawa, MD10, Koji Iwato, MD11*, Makoto Onizuka, MD12, Tatsuo Ichinohe, MD13, Yoshiko Atsuta, MD, Ph.D14,15* and Akiyoshi Takami, MD16

1Kyoto University Graduate School of Medicine, Kyoto, Japan
2National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
3Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
4Sapporo Hokuyu Hospital, Sapporo, Japan
5Institution of Biomedical research Innovation, Kobe, Japan
6Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
7Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
8Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
9Meitetsu hospital, Nagoya, Japan
10Department of Hematology and Oncology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
11Department of Transfusion, Hiroshima Red Cross Hospital, Hiroshima, Japan
12Tokai University School of Medicine, Isehara, Japan
13Hiroshima University, Hiroshima, Japan
14Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
15Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
16Aichi Medical University, Nagakute, Japan

3:15 PM

Anthony Selwyn Stein, MD1, Jeffrey Y. C. Wong, MD2*, Joycelynne Palmer, PhD3*, Margaret O'Donnell, MD4, David S. Snyder, MD5, Ni-Chun Tsai, Biostatition6*, Pablo Miguel Parker, MD7, Ricardo Spielberger, MD8, Len Farol, MD9*, Guido Marcucci, MD10, Eric Radany, MD11*, Tim Schultheiss, MD12*, An Liu, MD12*, Ibrahim Aldoss, MD13 and Stephen J. Forman, MD1

1Gehr Leukemia Center, City of Hope Medical Center, Duarte, CA
2City of Hope National Medical Center, Duarte, CA
3Department of Information Sciences, City of Hope, Duarte, CA
4City of Hope Medical Center, Duarte, CA
5Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
6Dept. of Information Sciences, City of Hope, Duarte, CA
7City of Hope, Duarte, CA
8City of Hope Transplant Program, HCT, So. Cal. Kaiser Permanente, Los Angeles, CA
9City of Hope Medical Center/So California Permanente Medical Group, Duarte, CA
10City of Hope, Gehr Family Center for Leukemia Research, Duarte, CA
11Radiation Oncology, City of Hope, Duarte, CA
12Radiation Physics, City of Hope, Duarte, CA
13Dept. of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

3:30 PM

Moussab Damlaj, MD1, Hassan B Alkhateeb, MD1*, Daniel K. Partain, MD2*, Jehad Almasri, MD3*, Mehrdad Hefazi, MD2*, Shahrukh K. Hashmi, MD1, Dennis A. Gastineau, MD4, Aref Al-Kali, MD3, Robert C Wolf, PharmD5, Naseema Gangat, MBBS1, Mark R Litzow, MD1, William J Hogan, MBChB1 and Mrinal M Patnaik, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MS
5Department of Pharmacy, Mayo Clinic, Rochester, MN

3:45 PM

Paul G. Richardson, MD1, Marcie Riches, MD2, Nancy A. Kernan, MD3, Joel A. Brochstein, MD4, Shin Mineishi, MD5, Amanda M. Termuhlen, MD6*, Sally Arai, MD7, Stephan A. Grupp, MD, PhD8, Eva C. Guinan, MD1, Paul L. Martin, MD, PhD9, Gideon Steinbach, MD, PhD10*, Amrita Krishnan11, Eneida R. Nemecek, MD12, Sergio A. Giralt, MD3, Tulio E. Rodriguez, MD13, Reggie Duerst, MD14, John J. Doyle, MD, FRCPC15, Joseph H. Antin, MD1, Angela R. Smith, MD, MS16, Leslie E. Lehmann, MD1, Richard E. Champlin, MD17, Alfred Gillio, MD4, Rajinder Bajwa, MBBS, MD, MRCP18, Ralph B. D'Agostino, PhD19*, Joseph Massaro, PhD19*, Maja Miloslavsky, PhD20*, Robin L. Hume, MS20*, Massimo Iacobelli, MD21, Bijan Nejadnik, MD20, Alison L. Hannah, MD20 and Robert J. Soiffer, MD1

1Dana-Farber Cancer Institute, Massachusetts General, Children’s Hospital, Boston, MA
2University of North Carolina Hospitals Bone Marrow and Stem Cell Transplant Clinic, North Carolina Cancer Hospital, Chapel Hill, NC
3Memorial Sloan Kettering Cancer Center, New York, NY
4Hackensack University Medical Center, Hackensack, NJ
5University of Alabama at Birmingham, Birmingham, AL
6Children’s Hospital Los Angeles, Los Angeles, CA
7Stanford University Medical Center, Stanford, CA
8Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA
9Duke University Medical Center, Durham, NC
10University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA
11City of Hope, Duarte, CA
12Oregon Health & Science University, Portland, OR
13Loyola University Medical Center, Chicago, IL
14Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
15CancerCare Manitoba and the University of Manitoba, Winnepeg, MB, Canada
16University of Minnesota, Minneapolis, MN
17MD Anderson Cancer Center, The University of Texas, Houston, TX
18The Ohio State University/Nationwide Children's Hospital, Columbus, OH
19Boston University, Boston, MA
20Jazz Pharmaceuticals, Palo Alto, CA
21Formerly Gentium SpA, Villa Guardia, Italy

4:00 PM

Uday R. Popat, MD1, Genevieve Ray2*, Roland L Bassett Jr.2*, Man-Yin C Poon1*, Benigno C. Valdez, PhD1, Sergej Konoplev, MD, PhD3, Sairah Ahmed, MD1, Amin M. Alousi, M.D.1, Borje Andersson, MD, PhD1, Qaiser Bashir, MD1*, Stefan O. Ciurea, MD1, Chitra M. Hosing, MD1, Roy Jones, MD, PhD1*, Partow Kebriaei, MD1, Issa F. Khouri, MD1, Stella Kim4*, Yago Nieto, MD, PhD1, Amanda L. Olson, MD1*, Betul Oran, MD1, Simrit Parmar, MD1, Muzaffar H. Qazilbash, MD1, Katy Rezvani, MD, PHD1*, Nina Shah, MD1, Elizabeth J. Shpall, MD1 and Richard E. Champlin, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH